MCK vs PFE · P/E 20, rev $403.43B vs P/E 20, rev $15.03B
McKesson Corporation (MCK) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the MCK and PFE stock pages for the full models.
Not investment advice.